Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IGHV5-78 (immunoglobulin heavy variable 5-78) is classified as a pseudogene that belongs to the immunoglobulin heavy chain variable (IGHV) gene family. These gene segments encode the variable domains of immunoglobulin heavy chains, which are critical for antigen binding and immune system diversity. However, as a pseudogene, IGHV5-78 does not produce a functional immunoglobulin protein[1]. While functional IGHV segments are necessary for the generation of antibody repertoires, pseudogenes like IGHV5-78 are generally not transcribed or translated into functional products and are not direct therapeutic targets. There are no known drugs or clinical biomarkers associated with IGHV5-78, and it does not play a defined role in human disease or therapy. Key clarification: While immunoglobulin gene segments as a group are central in B cell immunity and antibody generation, IGHV5-78 itself is notably distinguished as a pseudogene and therefore not a classical drug target or receptor[1]. If a functional IGHV gene is of interest (rather than this pseudogene), a different gene segment should be selected.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 5-78 pseudogene (IGHV5-78).